Stuart Roberts

In April 2016 Greenland Minerals updated its Feasibility Study on its Kvanefjeld Rare Earths Project in Greenland. Since the original Feasibility Study had been published in May 2015 the price of uranium, a significant by-product at Kvanefjeld, had come down, but Greenland Minerals had also made a lot of progress... Show More

Stuart Roberts

Pitt Street Research’s bread and butter is issuer-sponsored research of companies that are publicly traded on the ASX. We are big believers in the power of issuer sponsorship to enlarge the pool of quality, widely accessible research on ASX-listed companies, and thereby contribute to the overall efficiency of the Australian... Show More

Stuart Roberts

One of the more impressive re-brandings of a Life Science company that I've seen in recent years is Kazia Therapeutics, formerly Novogen. This company changed its name in late 2017 to reflect the acquisition from Genentech of an impressive new lead compound called GDC-0084, for the treatment of glioblastoma. We... Show More

Stuart Roberts

Every now and then when people ask me about building a portfolio of Life Science companies, I tell them that having a regenerative medicine stock in the portfolio is probably a good idea because we're going into a boom for that field globally. In July last year we at NDF... Show More

No comments.